VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial
Conferences
Levy, JH; Key, NS; Shorr, AF; Kurz, MA; Marder, VJ
Published in: BLOOD
November 18, 2011
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
1416 / 1416
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., Key, N. S., Shorr, A. F., Kurz, M. A., & Marder, V. J. (2011). VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial. In BLOOD (Vol. 118, pp. 1416–1416).
Levy, Jerrold H., Nigel S. Key, Andrew F. Shorr, Michael A. Kurz, and Victor J. Marder. “VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial.” In BLOOD, 118:1416–1416, 2011.
Levy JH, Key NS, Shorr AF, Kurz MA, Marder VJ. VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial. In: BLOOD. 2011. p. 1416–1416.
Levy, Jerrold H., et al. “VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial.” BLOOD, vol. 118, no. 21, 2011, pp. 1416–1416.
Levy JH, Key NS, Shorr AF, Kurz MA, Marder VJ. VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial. BLOOD. 2011. p. 1416–1416.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
1416 / 1416
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology